Clinical Trial ID: NCT05961709
The Phoenix Trial: Phase II trial of cemiplimab for the non-operative management of localized dMMR colon cancer
Status
Open
Conditions
Other
Phases
II (Cancer Control)
Age Group
Adult
Main Investiagtor
Landmann, Ron
Practice
GI
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05961709
Secondary Trial ID Number
2023-0228 / Phoenix
Keywords
Treatment